Granulosa Cell Tumor of the Ovary

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2018-03-05
Clinical Trial Update: Orteronel (TAK-700) in Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors. The Greko II Study. [Phase 2]
Phase 2 trial of Orteronel (TAK-700) in metastatic or advanced non-resectable granulosa cell ovarian tumors was terminated. No efficacy resu…